Effects of a resveratrol-containing nutraceutical on cardiac biomarkers, echocardiographic parameters, and oxidative stress in dogs with naturally occurring cardiac disease.

Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Frontiers in veterinary science in 2026 evaluated effects of a resveratrol-containing nutraceutical on cardiac biomarkers, echocardiographic parameters, and oxidative stress in dogs with naturally occurring cardiac disease..

Key Findings

Cardiac diseases such as myxomatous mitral valve disease (MMVD) and dilated cardiomyopathy (DCM) are common in dogs and are associated with progressive cardiac dysfunction and increased oxidative stress. Despite the widespread use of nutraceuticals in veterinary medicine, clinical evidence supporting their efficacy remains limited. This study aimed to evaluate the effects of a resveratrol-containing nutraceutical on cardiac biomarkers, echocardiographic parameters, oxidative stress, and safety in dogs with naturally occurring cardiac disease. This prospective, non-randomized, open-label study included 24 client-owned dogs allocated to a...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for canine patients.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.